KMID : 0986520150150020025
|
|
Korean Journal of Endoscrine Surgery 2015 Volume.15 No. 2 p.25 ~ p.33
|
|
Prognostic Value of p53 and Cyclin D1 in Papillary Thyroid Carcinoma
|
|
Seok Jae-Yeon
Chung Dong-Hae Chung Yoo-Seung Ryu Jung-Won Lee Young-Don
|
|
Abstract
|
|
|
Purpose: P53 and cyclin D1 have been evaluated as a prognostic marker in papillary thyroid carcinoma (PTC). However, the relationship between p53/cyclin D1 and PTC prognosis has not yet been confirmed. Therefore, we investigated the relationship between p53/cyclin D1 and PTC prognostic factors.
Methods: 919 patients with PTC were enrolled. Immunohistochemistry slides were reviewed for p53 and cyclin D1 immunoreactivity. Patients were classified into two groups according to the p53 and cyclin D1 grade: negative for ¡Â5% and positive for £¾5%. Medical records were reviewed to evaluate the prognostic factors, lymph node metastatic ratio (LNMR), and MACIS score. We analyzed patients based on p53/cyclin D1(?/?), p53/cyclin D1(?/£«), p53/cyclin D1(£«/?), p53/cyclin D1(£«/£«) separately for evaluation of independent effect of p53 and cyclin D1.
Results: Mean age of the patients was 49.73 years (range 15¡87), and tumor size was 1.19 cm (range 0.1¡5.0). P53 was positive in 809 (88.0%) and cyclin D1 was positive in 748 (81.4%). Positivity of p53 and cyclin D1 were correlated (r=0.448). There was no statistical significance in MACIS score. Positivity of p53 and cyclin D1 were related with larger tumor size, older age, early T stage, more tumor capsulation, and female. LNMR was higher in p53/cyclin D1(£«/?) than p53/cyclin D1(?/?) (P=0.036), p53/cyclin D1(?/£«) than p53/cyclin D1(?/?) (P=0.034), and p53/cyclin D1(£«/£«) than p53/cyclin D1(?/?) (P=0.007).
Conclusion: There was no consistent relationship between p53/cyclin D1 and worse prognostic factors of PTC. However, LNMR was higher in p53(£«) and cyclin D1(£«) cases independently, much more in p53/cyclin D1(£«/£«) than p53/cyclin D1(?/?).
|
|
KEYWORD
|
|
Papillary thyroid carcinoma, p53, Cyclin D1, Prognosis, Lymph node metasta-tic ratio
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|